Find out about the groundbreaking MDMA clinical trial for chronic nerve pain. Discover how this study aims to test the impact of MDMA compared to a placebo.
Jiangsu Alicorn Pharmaceutical Co. Ltd. has described AP2-associated protein kinase 1 (AAK1) inhibitors reported to be useful for the treatment of Alzheimer’s disease, bipolar disorder, Parkinson’s ...